Rxpress Global Pharmacy Limited - Company Profile

It is a pharma public limited company based in Gurugram, Haryana, India, established in 2020.
2020 Gurugram, Haryana, India Struck Off
Last Updated:
Access Report
About Rxpress Global Pharmacy Limited

Rxpress Global Pharmacy Limited, a struck off public limited company, was established on 12 September 2020 in Gurugram, Haryana, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909HR2020PLC089285. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Madhuri Devi Perala (Director), Adi Bhadra Reddy (Director), Arzoo Nasar (Director). It is based at Idc Ghora Chowk, Gurugram, Haryana, 125033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909HR2020PLC089285

  • Registration Number

    089285

  • Incorporation Date

    12 September 2020

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 5 Year, 6 Months
Company report

Rxpress Global Pharmacy Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rxpress Global Pharmacy Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rxpress Global Pharmacy Limited?
Current Directors
Name Designation Appointment Date Status
Madhuri Devi Perala Director 12 Sep 2020 Current
Adi Bhadra Reddy Director 12 Sep 2020 Current
Arzoo Nasar Director 12 Sep 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rxpress Global Pharmacy.

Enhance accessibility to Rxpress Global Pharmacy's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Rxpress Global Pharmacy revenue growth over time
Rxpress Global Pharmacy profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rxpress Global Pharmacy?

Unlock access to Rxpress Global Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rxpress Global Pharmacy?

Rxpress Global Pharmacy has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rxpress Global Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rxpress Global Pharmacy's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rxpress Global Pharmacy
Recent Activity within the Organization
  • Director Appointment

    Progress on Madhuri Devi Perala was appointed as a Director was appointed as a Director on 12 Sep 2020 & has been associated with this company since 5 years 6 months . was documented.

  • Director Appointment

    Adi Bhadra Reddy was appointed as a Director was appointed as a Director on 12 Sep 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Arzoo Nasar was appointed as a Director was appointed as a Director on 12 Sep 2020 & has been associated with this company since 5 years 6 months . was documented.

  • Company Incorporation

    Progress on Rxpress Global Pharmacy Limited was registered on 12 Sep 2020 with Roc Delhi & aged 5 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rxpress Global Pharmacy Limited?

The CIN of Rxpress Global Pharmacy Limited is U51909HR2020PLC089285.

Where is Rxpress Global Pharmacy Limited headquartered?

Rxpress Global Pharmacy Limited is headquartered at Idc Ghora Chowk, Gurugram, Haryana, 125033.

When was Rxpress Global Pharmacy Limited incorporated?

Rxpress Global Pharmacy Limited was incorporated on 12 September 2020.

Who are the current directors of Rxpress Global Pharmacy Limited?

The current directors of Rxpress Global Pharmacy Limited are

What is the primary industry of Rxpress Global Pharmacy Limited?

The primary industry of Rxpress Global Pharmacy Limited is Pharma.

Is Rxpress Global Pharmacy Limited a listed company?

Rxpress Global Pharmacy Limited is unlisted.

What is the capital structure of Rxpress Global Pharmacy Limited?

The authorized capital of Rxpress Global Pharmacy Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available